Medtronic plc — Director's Dealing 2019

Oct 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-10-01

Reporting Person: WHITE ROBERT JOHN (EVP & President MITG)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-01	Ordinary Shares	M	16817	$27.29	Acquired	68734	Direct
2019-10-01	Ordinary Shares	M	27353	$29.52	Acquired	96087	Direct
2019-10-01	Ordinary Shares	M	7995	$25.41	Acquired	104082	Direct
2019-10-01	Ordinary Shares	D	23553	$108.404	Disposed	80529	Direct
2019-10-01	Ordinary Shares	D	3800	$109.351	Disposed	76729	Direct
2019-10-01	Ordinary Shares	D	6945	$108.416	Disposed	69784	Direct
2019-10-01	Ordinary Shares	D	1050	$109.352	Disposed	68734	Direct
2019-10-01	Ordinary Shares	D	14517	$108.404	Disposed	54217	Direct
2019-10-01	Ordinary Shares	D	2300	$109.366	Disposed	51917	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-01	Stock Option (Right to Buy)	$27.29	M	16817	Disposed	2020-11-30	Ordinary Shares (16817)	Direct
2019-10-01	Stock Option (Right to Buy)	$29.52	M	27353	Disposed	2021-11-30	Ordinary Shares (27353)	Direct
2019-10-01	Stock Option (Right to Buy)	$25.41	M	7995	Disposed	2020-06-30	Ordinary Shares (7995)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.07 to $109.04, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.09 to $109.67, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.17 to $109.13, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.18 to $109.52, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.10 to $109.09, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.11 to $109.59, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.